Titlebook: Current Issues in Liver and Small Bowel Transplantation; Masaki Kitajima,Motohide Shimazu,Shigeyuki Kawachi Conference proceedings 2002 Sp

gait-cycle

gout109

Liver Splitting for Two Adult Patients and Domino Liver Transplantation: The Paul Brousse Experienceence with such splitting in two adults. Ex situ and in situ splitting were performed in 15 and 2 cases, respectively, generating 34 grafts (30 transplanted in our center, 4 shipped to two partner centers). Cold ischemia time, intraoperative transfusion volume, and hospitalization stay were comparabl

Provenance

吵鬧

dry-eye

Living-Donor Liver Transplantation Using Left-Liver Graft and Hepatic Vein Reconstructionaking the left liver with a caudate lobe graft is useful to overcome the problems of a small graft. Hepatic vein reconstruction appears necessary to allow proportional regeneration of the caudate lobe. A right-liver graft without a middle hepatic vein trunk is another option in this situation. Unles

容易懂得

Tartar

BRAND

Liver Transplantation for Hepatitis B and Cwith chronic viral hepatitis has not been as promising as for other liver disorders. A high rate of hepatitis recurrence in the allograft leading to a high incidence of graft and patient loss have led many transplant centers to reassess the use of LTx in these groups. Current strategies to prevent h

滴注

Strategies for the Treatment of Hepatitis B and C After Liver Transplantation of hepatitis, the morbidity and mortality of recipients with hepatitis B or C are high when compared with other indications such as alcoholic cirrhosis or Budd-Chiari syndrome. The spontaneous risk of viral recurrence in patients with hepatitis B has been effectively reduced by the use of hepatitis

淘氣

Prophylaxis and Posttransplant Treatment of Viral Hepatitis in Living-Donor Liver Transplantationrly events, or liver cirrhosis within 5 years as a late event. Reinfection with hepatitis C virus (HCV) may not involve harmful events, but the majority of recipients develop chronic hepatitis and are at risk of hepatocellular carcinoma..As prophylaxis for HBV, living-donor liver transplantation (LD